in the persantine-aspirin reinfarction study , part ii ( paris ii ) , 3,128 persons who had recovered from myocardial infarction , suffered from 4 weeks to 4 months previously , were randomized into two groups : dipyridamole ( persantine ) plus aspirin ( n = 1,563 ) and placebo ( n = 1,565 ) .
C0012582
dipyridamole
C0700020
persantine